Cardiff Oncology Inc — Quarterly Financial Statistics (NASDAQ:CRDF) | MetaTrader

Open full chart

Financials

Overview Statement Statistics Dividends

Quarterly Annual

Cash from operating activities -10.46 M-10.27 M-12.79 M-8.33 M-10.83 M-5.97 M -37.92 M Cash from investing activities -9.43 M4.51 M-14.58 M-4.98 M10.16 M10.75 M 1.34 M Cash from financing activities 7.43 M44.19 M3 000025 K2.55 M 2.58 M Free cash flow -10.46 M-10.27 M-12.79 M-8.33 M-10.83 M-5.97 M -37.92 M

News

Cardiff Oncology earnings beat by $0.08, revenue topped estimates

H.C. Wainwright reiterates Buy rating on Cardiff Oncology stock at $10

Cardiff Oncology, Inc. (CRDF) Discusses Management Transition and Onvansertib Phase II Data Update in RAS-Mutated mCRC Transcript

Why Did Cardiff Oncology Stock Plunge On Tuesday? - Cardiff Oncology (NASDAQ:CRDF)

Cardiff Oncology stock tumbles after Phase 2 trial data update

Cardiff Oncology appoints interim CEO amid leadership transition

Cardiff Oncology reports positive phase 2 data for cancer drug

Cardiff Oncology: What Storms Can We Expect In 2026? The Case For Measured Enthusiasm (NASDAQ:CRDF)

Cardiff Oncology stock initiated with Outperform rating by Noble Capital

Cardiff oncology reports positive results for onvansertib in leukemia trial

Cardiff Oncology at Guggenheim Conference: Promising Prospects for Onvansertib

Cardiff Oncology earnings beat by $0.04, revenue fell short of estimates